Haemonetics (HAE) Insider Trading & Ownership $69.39 -0.92 (-1.31%) As of 05/19/2025 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Haemonetics (NYSE:HAE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$2.66 M Get HAE Insider Trade Alerts Want to know when executives and insiders are buying or selling Haemonetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HAE Insider Buying and Selling by Quarter Haemonetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/26/2024Stewart W StrongInsiderSell4,312$91.15$393,038.80 7/11/2024Anila LingamneniEVPSell2,136$90.00$192,240.00 5/29/2024Michelle L BasilEVPSell12,990$88.08$1,144,159.20 5/29/2024Stewart W StrongInsiderSell8,857$87.53$775,253.21 5/20/2024Josep LlorensEVPSell987$95.08$93,843.96 5/20/2024Stewart W StrongInsiderSell686$95.11$65,245.46 (Data available from 1/1/2013 forward) HAE Insider Trading Activity - Frequently Asked Questions Who is on Haemonetics's Insider Roster? The list of insiders at Haemonetics includes Anila Lingamneni, Christopher Simon, Dan Goldstein, Josep Llorens, Laurie A Miller, Mark W Kroll, Michelle L Basil, and Stewart W Strong. Learn more on insiders at HAE. What percentage of Haemonetics stock is owned by insiders? 1.80% of Haemonetics stock is owned by insiders. Learn more on HAE's insider holdings. Which Haemonetics insiders have been selling company stock? The following insiders have sold HAE shares in the last 24 months: Anila Lingamneni ($810,657.32), Josep Llorens ($615,306.00), Michelle L Basil ($1,144,159.20), and Stewart W Strong ($1,324,602.99). How much insider selling is happening at Haemonetics? Insiders have sold a total of 43,593 Haemonetics shares in the last 24 months for a total of $3,894,725.51 sold. Haemonetics Key ExecutivesMr. Christopher A. Simon (Age 60)CEO, President & Director Compensation: $3.26MMs. Anila Lingamneni (Age 56)Executive VP & CTO Compensation: $1.09MMs. Michelle L. Basil (Age 52)Executive VP, General Counsel & Secretary Compensation: $1.26MMr. Josep Lluis Llorens (Age 62)Executive Vice President of Global Manufacturing & Supply Chain Compensation: $1.11MMs. Olga GuyetteSenior Director of Investor RelationsMr. Rajeev VarmaSenior Vice President of Strategy & Corporate DevelopmentMs. Laurie A. Miller (Age 51)Senior VP & Chief Human Resources Officer Dr. Jan Hartmann M.D.Senior VP & Chief Medical OfficerMr. Stewart W. Strong (Age 57)President of Global Hospital Compensation: $918.03kMs. Kerri DiPietroSenior Vice President of Global Quality Assurance More Insider Trading Tools from MarketBeat Related Companies Align Technology Insider Trades Merit Medical Systems Insider Trades ICU Medical Insider Trades DENTSPLY SIRONA Insider Trades QuidelOrtho Insider Trades Neogen Insider Trades STAAR Surgical Insider Trades Cerus Insider Trades OraSure Technologies Insider Trades Utah Medical Products Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NYSE:HAE) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s treachery A shocking bill has been put before the House of Representatives… Representative Brandon Gill wants Preside...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredAI Firm Enters America's Largest Medicaid MarketNew York's $95B system just approved a new AI healthcare platform. Here's what to know. A major shift in U....i2i Marketing Group, LLC | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.